Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry

Mojca Bizjak, Or Bruck, Sonja Praprotnik, Shani Dahan, Yehuda Shoenfeld*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


A 20-year-old man developed severe abdominal pain 1 week after being vaccinated with the first dose of quadrivalent human papillomavirus (HPV) vaccine (Gardasil®). Despite ongoing symptoms of nausea and pain, he received the second dose of the vaccine. Only 10 days later, laboratory results revealed significantly elevated pancreatic enzymes, and with concomitant abdominal pain and vomiting, he was diagnosed with acute pancreatitis. This case of acute pancreatitis after HPV vaccination is not a novel entity. Although confirming the relationship between pancreatitis and vaccine is challenging, some factors suggest a possible link, including the positive re-challenge upon repeated exposure to the vaccine, HPV vaccine as probable causal relationship to other autoimmune diseases and a probable mechanism of molecular mimicry. In conjunction with aluminum adjuvant, the induction of immunity through molecular mimicry may potentially culminate in production of cytotoxic autoantibodies with a particular affinity for pancreatic acinar cells.

Original languageEnglish
Pages (from-to)164-167
Number of pages4
JournalImmunologic Research
Issue number1
StatePublished - 1 Feb 2017


  • Adjuvant
  • Autoimmunity
  • Human papillomavirus
  • Molecular mimicry
  • Pancreatitis
  • Vaccine


Dive into the research topics of 'Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry'. Together they form a unique fingerprint.

Cite this